Balyasny Asset Management L.P. Invests $274,000 in TG Therapeutics, Inc. (NASDAQ:TGTX)
Balyasny Asset Management L.P. acquired a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 9,100 shares of the biopharmaceutical company’s stock, valued at approximately $274,000. Other institutional investors […]
Balyasny Asset Management L.P. acquired a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 9,100 shares of the biopharmaceutical company’s stock, valued at approximately $274,000. Other institutional investors […]
